Systems and Methods For Predictive Analytics for Site Initiation and Patient Enrollment
Methods and systems for predictive analytics for site initiation and patient enrollment are disclosed. One method may include: receiving a user's selection of one or more parameters associated with a clinical trial; accessing a database of data associated with a plurality of previous clinical trials; comparing the one or more parameters to the previous clinical trials; determining one or more factors associated with the clinical trial based on the comparison; and displaying the parameters and the factors on a display.
1 . A method for predictive analytics, the method comprising:
receiving a user's selection of one or more parameters associated with a clinical trial;
accessing a database of data associated with a plurality of previous clinical trials;
comparing the one or more parameters to the previous clinical trials;
determining one or more factors associated with the clinical trial based on the comparison; and
displaying the parameters and the factors on a display.
2 . The method of claim 1 , wherein receiving the user's selection of one or more parameters comprises determining that the user has adjusted one or more sliders associated with the parameters.
3 . The method of claim 1 , wherein the factors comprises one or more of: an estimated cost of the clinical trial, an estimated required number of patients, and a predicted length of time of the clinical trial.
4 . The method of claim 1 , wherein the previous clinical trials are associated with the clinical trial.
5 . The method of claim 1 , wherein at least one of the one or more parameters comprises a country in which to perform the clinical trial.
6 . The method of claim 5 , wherein the one or more parameters further comprises one or more of: the country's population, a prevalence of patients in the country, the country's regulatory environment, a number of clinical trials performed in the country, a length of time of the clinical trial, a length of time to start the clinical trial, historical data associated with the country, or a level of risk associated with conducting the clinical trial in the country.
7 . The method of claim 1 , further comprising:
receiving the user's selection of one or more new parameters associated with the clinical trial;
comparing the one or more new parameters to the previous clinical trials;
determining one or more additional factors associated with the clinical trial based on the comparison; and
updating the display to show the one or more additional factors.
8 . The method of claim 7 , wherein the new parameters comprise one or more of: a number of clinical trials in a therapeutic area, a length of time to start a clinical trial, investigator specific parameters, or data associated with previous clinical trials.
9 . The method of claim 8 , wherein the investigator specific parameters comprise one or more of: a number of trials that an investigator has run or a time it typically takes the investigator to enroll patients.
10 . The method of claim 8 , wherein the data associated with previous clinical trials comprises one or more of: a number of patients, a number of failures, a dropout rate, or a screen failure rate.
11 . A non-transitory computer readable medium comprising program code, which when executed is configured to cause a processor to:
receive a user's selection of one or more parameters associated with a clinical trial;
access a database of data associated with a plurality of previous clinical trials;
compare the one or more parameters to the previous clinical trials;
determine one or more factors associated with the clinical trial based on the comparison; and
display the parameters and the factors on a display.
12 . The non-transitory computer readable medium of claim 11 , wherein receiving the user's selection of one or more parameters comprises determining that the user has adjusted one or more sliders associated with the parameters.
13 . The non-transitory computer readable medium of claim 11 , wherein the previous clinical trials are associated with the clinical trial.
14 . The non-transitory computer readable medium of claim 11 , wherein the factors comprise one or more of: an estimated cost of the clinical trial, an estimated required number of patients, and a predicted length of time of the clinical trial.
15 . The non-transitory computer readable medium of claim 11 , wherein at least one of the one or more parameters comprises a country in which to perform the clinical trial.
16 . The non-transitory computer readable medium of claim 15 , wherein the one or more parameters further comprises one or more of: the country's population, a prevalence of patients in the country, the country's regulatory environment, a number of clinical trials performed in the country, a length of time of the clinical trial, a length of time to start the clinical trial, historical data associated with the country, or a level of risk associated with conducting the clinical trial in the country.
17 . The non-transitory computer readable medium of claim 11 , further comprising program code, which when executed by the processor is configured to cause the processor to:
receive the user's selection of one or more new parameters associated with the clinical trial;
comparing the one or more new parameters to the previous clinical trials;
determining one or more additional factors associated with the clinical trial based on the comparison; and
updating the display to show the one or more additional factors.
18 . The non-transitory computer readable medium of claim 17 , wherein the new parameters comprise one or more of: a number of clinical trials in a therapeutic area, a length of time to start a clinical trial, investigator specific parameters, or data associated with previous clinical trials.
19 . The non-transitory computer readable medium of claim 18 , wherein the investigator specific parameters comprise one or more of: a number of trials that an investigator has run or a time it typically takes the investigator to enroll patients.
20 . The non-transitory computer readable medium of claim 18 , wherein the data associated with previous clinical trials comprises one or more of: a number of patients, a number of failures, a dropout rate, or a screen failure rate.